SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001601830-24-000091
Filing Date
2024-06-27
Accepted
2024-06-27 08:16:04
Documents
22
Period of Report
2024-06-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rxrx-20240626.htm   iXBRL 8-K 32662
2 EX-1.1 exhibit11-underwritingagre.htm EX-1.1 270899
3 EX-5.1 exhibit51-wsgropinion2024.htm EX-5.1 13982
4 EX-99.1 exhibit991-rxrxpressreleas.htm EX-99.1 10420
5 EX-99.2 exhibit992-rxrxpricingpres.htm EX-99.2 11237
9 image_01.jpg GRAPHIC 309416
10 image_02.jpg GRAPHIC 309416
11 image_1.jpg GRAPHIC 68421
12 image_11.jpg GRAPHIC 288
13 image_12.jpg GRAPHIC 288
  Complete submission text file 0001601830-24-000091.txt   1483660

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxrx-20240626.xsd EX-101.SCH 1907
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxrx-20240626_lab.xml EX-101.LAB 21629
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxrx-20240626_pre.xml EX-101.PRE 12512
25 EXTRACTED XBRL INSTANCE DOCUMENT rxrx-20240626_htm.xml XML 2746
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40323 | Film No.: 241075421
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)